previous compound ID: 1140 next compound
InChIKey: KBAUFVUYFNWQFM-UHFFFAOYSA-N
SMILES: CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"R Robert" "B Kus" "J Goepp" "E Matthes" "JW Hanrahan" "J Liao" "DY Thomas" "GW Carlile" "D Rotin" "SD Macknight"

chemical graph of compound 1140





CID is 11224
synonyms found at PubChem are:
Doxylamine succinate, 562-10-7, Decapryn, Doxylamine (succinate), Evigoa D, A-H Injection, Decapryn Succinate, Doxylamine succinate salt, Unisom, Alsadorm, Gittalun, Mereprine, Sedaplus, Doxy-sleep-aid, Doxylamine succinate (1:1), Hoggar N, Decapryn succinate (1:1), Doxylamine hydrogen succinate, CCRIS 4811, EINECS 209-228-7, NSC 74772, Doxylamine succinate [USP], AI3-23993, MLS000028417, 2-Dimethylaminoethoxyphenylmethyl-2-picoline succinate (1:1), CHEBI:82461, Dimethylaminoethoxy-methyl-benzyl-pyridine succinate, 2-Dimethylaminoethoxyphenylmethyl-2-picoline succinate, SMR000058436, Decapryn (TN), DSSTox_CID_552, Phenyl2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether succinate, 2-(alpha-(2-Dimethylaminoethoxy)-alpha-methylbenzyl)pyridine succinate, Doxylamine-d5 Succinate, 2-(alpha(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine succinate (1:1), Doxylamine succinate (USP), alpha-(2-Dimethylaminoethoxy)-alpha-methyl-alpha-phenyl-2-picoline acid succinate, Butanedioic acid, compd. with N,N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine (1:1), Butanedioic acid, compd. with N,N-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]ethanamine (1:1), DSSTox_RID_75656, DSSTox_GSID_20552, C21H28N2O5, N,N-dimethyl-2-(1-phenyl-1-(pyridin-2-yl)ethoxy)ethanamine succinate, N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine succinate, N,N-Dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]ethenamine succinate, Topcare sleep aid, Ethanamine, N,N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)-, butanedioate (1:1), Pyridine, 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)-, succinate (1:1), SR-01000003036, EQUALINE SLEEP AID, Doxylamine succinate liquid, Decarpyn succinate (1:1), Safetussin, N,N-dimethyl-2-[1-phenyl-1-pyridin-2-ylethoxy]ethanamine succinate, butanedioic acid;N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine, C17H22N2O.C4H6O4, NCGC00017028-02, CAS-562-10-7, Prestwick_887, Opera_ID_566, doxylamine; succinic acid, AC1L1WW1, AC1Q5VR4, Pyridine, succinate (1:1), MLS000758288, MLS001076141, MLS001424137, MLS002222274, SCHEMBL160443, SPECTRUM1500267, CHEMBL1200392, DTXSID7020552, HMS502K03, MolPort-003-666-172, HMS1568E15, HMS1920K04, HMS2051F14, HMS2091B09, HMS2095E15, HMS2231G05, HMS3261E17, HMS3370K04, HMS3393F14, HMS3652H19, HMS3712E15, Pharmakon1600-01500267, BCP24067, HY-A0069, NSC74772, Tox21_113515, Tox21_202078, Tox21_302861, Tox21_500348, BG0679, CCG-38929, MFCD00056168, NSC-74772, NSC756752, s4240, AKOS025310916, Tox21_113515_1, AC-4487, API0002494, CCG-101033, CS-3232, LP00348, LS-1380, NC00283, NSC-756752, NCGC00016140-02, NCGC00016140-03, NCGC00016140-04, NCGC00021147-11, NCGC00089789-03, NCGC00093785-01, NCGC00093785-02, NCGC00093785-03, NCGC00256517-01, NCGC00259627-01, NCGC00261033-01, AN-11902, AS-13661, BC678008, CPD000058436, Q835, SAM001247030, ACM1216840946, AB0017830, KB-295989, EU-0100348, FT-0082833, FT-0625595, WLN: T6NJ BX1&R&O2N1&1 &OV2VO, C19414, D 3775, D-9200, D02327, J10070, SR-01000003036-2, SR-01000003036-6, SR-01000003036-9, (Dimethylamino)ethoxy-methyl-benzyl-pyridine succinate, F2173-1155, [[[(2-Dimethylamino)ethoxy]phenyl]methyl]-2-picoline succinate, 2-[a-[2-(Dimethylamino)ethoxy]-a-methylbenzyl]pyridine succinate, Doxylamine Hydrogen Succinate 1.0 mg/ml in Methanol (as free base), butanedioic acid,N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine, butanedioic acid; N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine, Doxylamine succinate, United States Pharmacopeia (USP) Reference Standard, n,n-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine butanedioate, N,N-dimethyl-2-[1-phenyl-1-(2-pyridyl)ethoxy]ethanamine; succinic acid, Phenyl2-pyridylmethyl-(.beta.-N,N-dimethylamino)ethyl ether succinate, 2-[[.alpha.-(2-Dimethylamino)ethoxy]-.alpha.-methylbenzyl]pyridine succinate, Butanedioic acid,N-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]ethanamine (1:1), Doxylamine for system suitability, European Pharmacopoeia (EP) Reference Standard, Doxylamine hydrogen succinate, European Pharmacopoeia (EP) Reference Standard, Doxylamine Succinate, Pharmaceutical Secondary Standard; Certified Reference Material, 121367-03-1, Succinic acid, compd. with 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine (1:1), Succinic acid, compd. with 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine (1:1) (8CI), Succinic acid, compd. with 2-[.alpha.-[2-(dimethylamino)ethoxy]-.alpha.-methylbenzyl]pyridine (1:1), dimethyl[2-(1-phenyl-1-(2-pyridyl)ethoxy)ethyl]amine, butanedioic acid, SBB057413, AKOS024366248, MCULE-7394342520, ST50999670